- Home
- BRZE vs APGE Comparison
BRZE vs APGE Comparison
Compare BRZE & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRZE
- APGE
- Stock Information
- Founded
- BRZE 2011
- APGE 2022
- Country
- BRZE United States
- APGE United States
- Employees
- BRZE N/A
- APGE N/A
- Industry
- BRZE Computer Software: Prepackaged Software
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRZE Technology
- APGE Health Care
- Exchange
- BRZE Nasdaq
- APGE Nasdaq
- Market Cap
- BRZE 3.6B
- APGE 3.0B
- IPO Year
- BRZE 2021
- APGE 2023
- Fundamental
- Price
- BRZE $44.31
- APGE $47.45
- Analyst Decision
- BRZE Strong Buy
- APGE Strong Buy
- Analyst Count
- BRZE 20
- APGE 6
- Target Price
- BRZE $54.30
- APGE $75.40
- AVG Volume (30 Days)
- BRZE 1.9M
- APGE 623.0K
- Earning Date
- BRZE 12-09-2024
- APGE 11-12-2024
- Dividend Yield
- BRZE N/A
- APGE N/A
- EPS Growth
- BRZE N/A
- APGE N/A
- EPS
- BRZE N/A
- APGE N/A
- Revenue
- BRZE $563,967,000.00
- APGE N/A
- Revenue This Year
- BRZE $27.28
- APGE N/A
- Revenue Next Year
- BRZE $16.96
- APGE N/A
- P/E Ratio
- BRZE N/A
- APGE N/A
- Revenue Growth
- BRZE 28.31
- APGE N/A
- 52 Week Low
- BRZE $29.18
- APGE $25.85
- 52 Week High
- BRZE $61.53
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- BRZE 68.44
- APGE 49.00
- Support Level
- BRZE $42.67
- APGE $43.69
- Resistance Level
- BRZE $45.78
- APGE $48.85
- Average True Range (ATR)
- BRZE 2.26
- APGE 3.97
- MACD
- BRZE 0.07
- APGE 0.26
- Stochastic Oscillator
- BRZE 74.35
- APGE 48.79
About BRZE Braze Inc.
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates a majority of its revenue from the United States.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.